Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS

被引:153
作者
Crespo, ME [1 ]
Gálvez, J [1 ]
Cruz, T [1 ]
Ocete, MA [1 ]
Zarzuelo, A [1 ]
机构
[1] Univ Granada, Sch Pharm, Dept Pharmacol, E-18071 Granada, Spain
关键词
D O I
10.1055/s-2006-960838
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The intestinal anti-inflammatory activity of two flavonoids, hesperidin and diosmin, was evaluated in the acute stage of the trinitrobenzenesulfonic acid (TNBS) model of rat colitis. The results obtained showed that pretreatment with diosmin (10 mg/kg) or hesperidin (10 and 25 mg/kg) reduced colonic damage compared to TNBS control rats. This effect was confirmed biochemically by a reduction in colonic myeloperoxidase activity compared to non-treated colitic animals. Colonic glutathione levels in colitic animals were significantly increased after hesperidin or diosmin treatment. Diosmin decreased colonic MDA production and inhibited LTB4 synthesis, whereas hesperidin failed to do so. Conversely, only hesperidin improved colonic fluid absorption, which was impaired in colitic animals. In conclusion, both diosmin and hesperidin were able to prevent colonic inflammation, acting via a mechanism in which protection against oxidative insult may play a role.
引用
收藏
页码:651 / 653
页数:3
相关论文
共 19 条
  • [1] DISRUPTION OF COLONIC ELECTROLYTE TRANSPORT IN EXPERIMENTAL COLITIS
    BELL, CJ
    GALL, DG
    WALLACE, JL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 268 (04): : G622 - G630
  • [2] Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis
    Bertran, X
    Mane, J
    FernandezBanares, F
    Castella, E
    Bartoli, R
    Ojanguren, I
    Esteve, M
    Gassull, MA
    [J]. GUT, 1996, 38 (06) : 899 - 904
  • [3] Oral administration of rutoside can ameliorate inflammatory bowel disease in rats
    Cruz, T
    Gálvez, J
    Ocete, MA
    Crespo, ME
    de Medina, FS
    Zarzuelo, A
    [J]. LIFE SCIENCES, 1998, 62 (07) : 687 - 695
  • [4] DeMedina FS, 1996, J PHARMACOL EXP THER, V278, P771
  • [5] EXPERIMENTAL-MODELS OF INFLAMMATORY BOWEL-DISEASE
    ELSON, CO
    SARTOR, RB
    TENNYSON, GS
    RIDDELL, RH
    [J]. GASTROENTEROLOGY, 1995, 109 (04) : 1344 - 1367
  • [6] FRENTLAND DJ, 1990, J PHARMACOL EXP THER, V255, P572
  • [7] ORAL ADMINISTRATION OF PURIFIED MICRONIZED FLAVONOID FRACTION SUPPRESSES LEUKOCYTE ADHESION IN ISCHEMIA-REPERFUSION INJURY - IN-VIVO OBSERVATIONS IN THE HAMSTER SKIN FOLD
    FRIESENECKER, B
    TSAI, AG
    ALLEGRA, C
    INTAGLIETTA, M
    [J]. INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1994, 14 (1-2): : 50 - 55
  • [8] FLAVONOID INHIBITION OF ENZYMATIC AND NONENZYMIC LIPID-PEROXIDATION IN RAT-LIVER DIFFERS FROM ITS INFLUENCE ON THE GLUTATHIONE-RELATED ENZYMES
    GALVEZ, J
    DELACRUZ, JP
    ZARZUELO, A
    DELACUESTA, FS
    [J]. PHARMACOLOGY, 1995, 51 (02) : 127 - 133
  • [9] HACKETT AM, 1986, PLANT FLAVONOIDS BIO, P177
  • [10] JEAN T, 1994, ANGIOLOGY, V45, P554, DOI 10.1177/000331979404500610